No Differences in Levels of Circulating Progenitor Endothelial Cells or Circulating Endothelial Cells Among Patients Treated With Ticagrelor Compared With Clopidogrel During Non–ST‐Segment–Elevation Myocardial Infarction

BACKGROUND: Ticagrelor use during acute coronary syndromes demonstrated a decrease in all‐cause mortality in the PLATO (Platelet Inhibition and Patient Outcomes) trial. This effect has been attributed to a non–platelet‐derived improvement in endothelial function. The aim of this study was to determi...

Descripción completa

Detalles Bibliográficos
Autores principales: Diego‐Nieto, Alejandro, Vidriales, Maria B., Alonso‐Orcajo, Norberto, Moreno‐Samos, Jose C., Martin‐Herrero, Francisco, Carbonell, Raul, Cid, Belen, Cruz‐Gonzalez, Ignacio, Martin‐Moreiras, Javier C., Cuellas, Carlos, Pascual, Cristina, Lopez‐Benito, Maria, Sanchez, Pedro L., Fernandez‐Vazquez, Felipe, de Prado, Armando Perez
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404906/
https://www.ncbi.nlm.nih.gov/pubmed/30371302
http://dx.doi.org/10.1161/JAHA.118.009444

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404906/
https://www.ncbi.nlm.nih.gov/pubmed/30371302
http://dx.doi.org/10.1161/JAHA.118.009444

Ejemplares similares